Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-GPCR-Cannabinoid Receptor-GW833972A
GW833972A

Chemical Structure : GW833972A

CAS No.: 1092502-33-4

GW833972A (GW 833972A, GW-833972A)

Catalog No.: PC-26472Not For Human Use, Lab Use Only.

GW833972A is a potent, selective CB2 receptor agonist with pEC50 of 7.3 and 7.5 for human and rat CB2 receptors respecitvely, shows 1000-fold selectivity over CB1 receptor, also binds BMAL2 with high affinity and facilitates its protein degradation.

Packing Price Stock Quantity
5 mg $158 In stock
10 mg $238 In stock
25 mg $398 In stock
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

GW833972A is a potent, selective CB2 receptor agonist with pEC50 of 7.3 and 7.5 for human and rat CB2 receptors respecitvely, shows 1000-fold selectivity over CB1 receptor, also binds BMAL2 with high affinity and facilitates its protein degradation.
GW833972A (0.3-300 uM) induced a concentration-dependent inhibition of the guinea-pig vagus nerve activity, stimulated by either capsaicin, hypertonic saline or PGE2.
GW833972A abolished Capsaicin-induced depolarizations at 300 μM with EC50 of 33.9 uM.
GW833972A also inhibited citric acid-induced cough but not plasma extravasation in the guinea-pig and this effect was blocked by a CB2 receptor antagonist.
GW833972A reduced RAD51 expression, leading to an accumulation of DNA damage, decreased cell viability and reduced OCCC tumor growth.
GW833972A enhanced the effectiveness of Poly (ADP-ribose) polymerase inhibitor (PARPi) treatments in BMAL2-expressing OCCC.

Physicochemical Properties

M.Wt 444.24
Formula C18H14Cl2F3N5O
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

2-((3-chlorophenyl)amino)-N-(pyridin-4-ylmethyl)-4-(trifluoromethyl)pyrimidine-5-carboxamide hydrochloride

References

1. Belvisi MG, et al. Br J Pharmacol. 2008 Oct;155(4):547-57.

2. Mlost J, et al. Biomed Pharmacother. 2021 Apr;136:111283.

3. Tan GYT, et al. EMBO Mol Med. 2026 Apr 3. doi: 10.1038/s44321-026-00414-8.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: